According to the recent study the neuromodulation market is projected to grow at a CAGR of 7%-9% from 2020 to 2025. Growth in this market is primarily driven by increasing research and development activities in neurology and growing prevalence of neurological disorders.
Browse XX figures /
charts and XX tables in this 150-page report to understand trends,
opportunities and forecast in neuromodulation market by technology (internal
neuromodulation (spinal cord stimulation, deep brain stimulation, vagus nerve
stimulation, sacral nerve stimulation, and gastric electrical stimulation) and
external neuromodulation (transcutaneous electrical nerve stimulation (TENS),
transcranial magnetic stimulation (TMS), and respiratory electrical stimulation
(RES))), biomaterial (metallic biomaterials, polymeric biomaterials, and
ceramic biomaterials), application (spinal cord stimulation, deep brain
stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric
electrical stimulation, transcutaneous electrical nerve stimulation,
transcranial magnetic stimulation, and respiratory electrical stimulation), and
region (North America, Europe, Asia Pacific, and Rest of the World).
Download sample report
and view detailed Table of Content by clicking on below link https://www.lucintel.com/neuromodulation-reportcolonopt-trends,-forecast-and-competitive-analysis.aspx
“Internal neuromodulators market is expected to remain the largest
segment during the forecast period.”
Based on technology, the
neuromodulation market is segmented into internal neuromodulation (spinal cord
stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve
stimulation, and gastric electrical stimulation) and external neuromodulation
(transcutaneous electrical nerve stimulation (TENS), transcranial magnetic
stimulation (TMS), and respiratory electrical stimulation (RES)). Lucintel
forecasts that the internal neuromodulation market is expected to remain the
largest segment during the forecast period due to rising prevalence of neurological disorders, increasing
research into expanding the applications of neuromodulation, and awareness of
neurodegenerative disorders.
“Within the neuromodulation market, the deep brain stimulation segment
is expected to remain the largest application.”
Based on application,
the deep brain stimulation segment is expected to witness the largest segment over
the forecast period due to the rising incidence of generic diseases and growing
R&D activity for neuromodulation applications.
“North America will dominate the neuromodulation market in near
future.”
North America is
expected to be the highest growth over the forecast period over the forecast
period due to rise in geriatric population, their vulnerability for
neurological disorders, increase in incidence of neurological diseases, such as
Alzheimer’s and Parkinson’s diseases, and the increase in awareness of the
safety and efficacy of neurostimulator devices in the region.
Download Brochure of this report by clicking on https://www.lucintel.com/neuromodulation-reportcolonopt-trends,-forecast-and-competitive-analysis.aspx
Major players of neuromodulation
market are adopting various growth strategies like new product launches,
expansions, merger and acquisitions, partnerships, agreements, and
collaborations to expand their presence in this market. Medtronic, Boston
Scientific, Abbott, LivaNova, Synapse Biomedical, Nevro, NeuroSigma, NeuroPace,
Neuronetics, and BioControl Medical are among the major neuromodulation providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or click on this link https://www.lucintel.com/neuromodulation-reportcolonopt-trends,-forecast-and-competitive-analysis.aspx or helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer
solutions for you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times. For further information, visit www.lucintel.com
Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally
Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx
Endoscopy
Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor
Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
Urology
Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx
Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx
No comments:
Post a Comment